Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Targeted treatment of solid tumors and hematologic malignancies.
PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
Treatment of patients with castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Approved for use in oncology care according to FDA-approved indications.
Metastatic Castration-Resistant Prostate Cancer (mCRPC) and High-Risk Castration-Sensitive Prostate Cancer in combination with prednisone.
Approved for use in oncology care according to FDA-approved indications.